Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.
- DOI
- 10.1080/10837450.2026.2757869
- Published
- 2026 Nov 3
- Container
- Pharmaceutical development and technology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/10837450.2026.2757869,
title = {Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.},
author = {Fatease AA and Abdelkader H and Fathalla Z and Mousa HS and Abdel-Aleem JA and Abou-Taleb HA},
year = {2026},
journal = {Pharmaceutical development and technology},
doi = {10.1080/10837450.2026.2757869},
url = {https://doi.org/10.1080/10837450.2026.2757869}
}RIS
TY - JOUR TI - Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles. AU - Fatease AA AU - Abdelkader H AU - Fathalla Z AU - Mousa HS AU - Abdel-Aleem JA AU - Abou-Taleb HA PY - 2026 JO - Pharmaceutical development and technology DO - 10.1080/10837450.2026.2757869 UR - https://doi.org/10.1080/10837450.2026.2757869 ER -
APA
AA, F., H, A., Z, F., HS, M., JA, A., & HA, A. (2026). Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.. Pharmaceutical development and technology. https://doi.org/10.1080/10837450.2026.2757869
Source records
- pubmed · retrieved 2026-11-10T15:11:58.553Z